Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, Influenza vaccine and FDA
Novavax’s stock slides 19% after FDA puts clinical hold on COVID and flu vaccine candidates
Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.
Novavax says FDA put hold on combination Covid-flu shot and influenza vaccine; shares plunge
The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a phase two trial.
Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines
Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and standalone flu inoculation, sending shares down sharply.
Opinion
12h
Opinion
Commentary: Your vaccine list should include COVID-19 update
As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...
10d
Novavax gets EU authorization for updated COVID vaccine targeting JN.1 strain
The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, ...
2d
Novavax’s Regulatory Setback and Mid-Term Underperformance: An Analyst’s Perspective
Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Reaches tentative union deal
Judge unseals new evidence
La Nina could arrive soon
Frozen waffles recalled
Republicans appeal ruling
Philip Zimbardo dies at 91
NC breaks turnout record
Ex-MN congressman dies
Nationwide blackout in Cuba
PG&E shuts off power
Netanyahu's home targeted
NK sending troops to RU?
Probes near miss in Austin
Emergency abortion ruling
Bladder cancer drug pulled
To furlough 700 workers
US deficit reaches $1.8T
At decade-high level
Challenges military listing
$4M LAPD fentanyl seizure
Opioid suits settlement deal
Antitrust ruling delayed
G7 ministers back Ukraine
FAA opens new safety review
School shooting report
Three Americans detained
Fire prompts evacuations
OK classroom Bible suit
Feedback